Curing cancer, from bench to bedside

Our immune system is like a well-trained security network, constantly scanning the body for threats. So, how is it that some harmful cells manage to slip by unnoticed? In this episode, we speak to computational biologist, Dr Clare Puttick, about how cancer cells can evade detecti ...  Afficher plus

What if the missing piece in diagnosing, and even treating, a rare disease was hiding in plain sight? For one such condition, mevalonate kinase deficiency, which affects at least one in a million people globally, that piece may now have been uncovered. In this episode, Garvan's P ...  Afficher plus

Cancer is still one of the most common diseases worldwide, and one of the top causes of death – also because there is no known cure yet. As this makes prevention all the more crucial for patients, we spoke to renowned researcher for biomedicine and scientific author Bernd Bodenmi ...  Afficher plus

An interview with Dr Chloe Anthias, medical director of the new Cell Collection Centre has just opened by Anthony Nolan charity as part of our NIHR Nottingham Clinical Research Facility. Links a little while ago I talked to Prof Mark Bishton, who’s an oncologist at the hospital a ...  Afficher plus

Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with prostate cancer. 

In this episode, Dr. Diane Reidy-Lagunes talks to medical oncologist and scientist Dr. Jedd Wolchok and cancer survivor Grace Dunn. Together, they help decode the emerging new defense against cancer: immunology. For more information or to ask a question, please visit MSKCC.org/po ...  Afficher plus